Shanghai Labway Clinical Laboratory Co Ltd
SZSE:301060
Shanghai Labway Clinical Laboratory Co Ltd
SZSE:301060
Price:
10.42 CNY
1.36%
Market Closed
Updated:
May 18, 2024
Shanghai Labway Clinical Laboratory Co Ltd
Interest Income Expense
|
Shanghai Labway Clinical Laboratory Co Ltd
Interest Income Expense Peer Comparison
Comparables:
1099
601607
600998
C
600511
000963
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Shanghai Labway Clinical Laboratory Co Ltd
SZSE:301060
|
Interest Income Expense
-¥5.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Interest Income Expense
-¥3.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-8%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Interest Income Expense
-¥1.1B
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Interest Income Expense
-¥1.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-14%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Interest Income Expense
¥526.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Interest Income Expense
-¥248.5m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-20%
|
See Also
What is Shanghai Labway Clinical Laboratory Co Ltd's Interest Income Expense?
Interest Income Expense
-5.3m
CNY
-5.3m
CNY
Based on the financial report for Dec 31, 2023, Shanghai Labway Clinical Laboratory Co Ltd's Interest Income Expense amounts to -5.3m CNY.
What is Shanghai Labway Clinical Laboratory Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
-38%
-38%
Over the last year, the Interest Income Expense growth was -38%.
You don't have any saved screeners yet
